30mCi radioactive iodine achieving comparative excellent response in intermediate/high-risk nonmetastatic papillary thyroid cancer: a propensity score matching study

ConclusionsEfficacy of low-dose RAI therapy was similar to that of high-dose for ablation and achieving ER in Chinese nonmetastatic intermediate- to high-risk PTC patients. High-dose RAI could not rectify ablation failure or non-ER rates in PTC patients withBRAFV600E, lymph node metastases, or unfavorable thyroglobulin levels.

http://link.springer.com/10.1007/s12020-018-1724-z

Source: Endocrine - November 17, 2018 Category: Endocrinology Source Type: research